• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News
  • Login
Upgrade
My Uttarpradesh
  • Home
  • Uttar Pradesh
  • India
    • National
    • State News
  • Tech
    • App News
  • Education
  • Entertainment
  • Lifestyle
    • Fashion & Beauty
    • Health & Fitness
    • Food
      • Recipes
    • Photography
  • Others
    • Auto
    • Finance/Money
    • Astrology
    • Science
    • Agriculture
    • Science
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • Uttar Pradesh
  • India
    • National
    • State News
  • Tech
    • App News
  • Education
  • Entertainment
  • Lifestyle
    • Fashion & Beauty
    • Health & Fitness
    • Food
      • Recipes
    • Photography
  • Others
    • Auto
    • Finance/Money
    • Astrology
    • Science
    • Agriculture
    • Science
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
My Uttarpradesh
No Result
View All Result
Home Health & Fitness

AustralaSian COVID-19 Trial opens in India

My UP Desk by My UP Desk
March 1, 2021
in Health & Fitness, National
0
Share on FacebookShare on Twitter

New Delhi: AustralaSian COVID-19 Trial (ASCOT) has been expanded into India, with the first patients recruited last week to the first two sites, Christian Medical College and Hospital Ludhiana in Punjab and Sterling Multispecialty Hospital in Pune, Maharashtra. Australasia is a region that comprises Australia, New Zealand, and some neighboring islands.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.George Institute for Global Health is an independent medical research institute headquartered in Australia with offices in China, India and the United Kingdom.

You Might Also Like

“Empowering Women Through Innovative Healthcare: Dr. Monika Agarwal, Leading Cosmetic Gynaecologist and Laparoscopic Surgeon in Ghaziabad”

MedscapeIndia takes initiative to protect doctors through a ‘Health Tribunal Law’

Use of Artificial Intelligence (AI) in Angioplasty, Dr. Ankur Phatarpekar announces the integration of the latest OCT

ASCOT aims to discover which existing treatments are most effective in patients hospitalised with COVID-19 and whether they will prevent patients deteriorating to the point of needing a ventilator in the Intensive Care Unit.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.

ASCOT Principal Investigator, Associate Professor Steven Tong, a Royal Melbourne Hospital infectious diseases clinician and co-lead of clinical research at the Doherty Institute said that while ASCOT began as an Australian and New Zealand trial, expanding internationally to allow more widespread access to investigational treatments was crucial.

“A key principle of the trial is equity in terms of access to experimental treatments that could potentially have benefits for patients,” Associate Professor Tong said.

“The ASCOT Management Team and Leadership Group recognised early in the course of the trial that for it to have generalisability, external validity and be adequately powered, it would need to be expanded to international sites.”

India, like many other middle and low-income countries, is facing a severe epidemic of COVID-19. The number of patients with COVID-19 in India remains significantly higher than in Australia and New Zealand, and access to experimental treatments is limited.

Bala Venkatesh, Professorial Fellow at the George Institute for Global Health, said that while there are other ongoing clinical trials in India for COVID-19, the novel combinations of treatments included in ASCOT will provide greater opportunities to patients for accessing new treatments.

“We are confident that the study questions being asked are of priority to Indian patients and participating trial sites, and feasible to address in India,” said Professor Venkatesh.

One new treatment that’s recently been added to ASCOT is Nafamostat, which in laboratory experiments has shown to block SARS-COV-2 from entering human cells and be far more potent than Remdesivir.

“Nafamostat is mainly used in Korea and Japan as a treatment for acute pancreatitis and some blood clotting conditions. Of all drugs with potency data from laboratory studies using human cell lines, nafamostat appears to be the most potent against SARS-CoV-2 and maybe the only drug where blood concentrations almost always exceed levels required to stop the virus from replicating,” explained Associate Professor Tong.

“It is also likely that Nafamostat will reach high levels in the lungs where the SARS-CoV-2 virus causes so much of its problems. What’s more, it has a favourable safety profile.”

The ASCOT Steering Committee recently made the decision to cease enrolment into the convalescent plasma arm of the trial following a media release issued by the UK’s RECOVERY trial, which reported no benefit to patients compared with standard of care. (India Science Wire)

Tags: ASCOTAustralaSianChristian Medical College and HospitalClinical TrialCOVID-19Sterling Multispecialty Hospital
Previous Post

Dr. Harsh Vardhan dedicates two new databases to the nation

Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

My UP Desk

My UP Desk

Related Posts

“Empowering Women Through Innovative Healthcare: Dr. Monika Agarwal, Leading Cosmetic Gynaecologist and Laparoscopic Surgeon in Ghaziabad”
Health & Fitness

“Empowering Women Through Innovative Healthcare: Dr. Monika Agarwal, Leading Cosmetic Gynaecologist and Laparoscopic Surgeon in Ghaziabad”

by My UP Desk
September 4, 2023
MedscapeIndia takes initiative to protect doctors through a ‘Health Tribunal Law’
Health & Fitness

MedscapeIndia takes initiative to protect doctors through a ‘Health Tribunal Law’

by My UP Desk
August 18, 2023
Use of Artificial Intelligence (AI) in Angioplasty, Dr. Ankur Phatarpekar announces the integration of the latest OCT
Health & Fitness

Use of Artificial Intelligence (AI) in Angioplasty, Dr. Ankur Phatarpekar announces the integration of the latest OCT

by My UP Desk
July 26, 2023
Kosmoderma continues to be the big player in the skincare industry with its new and innovative launch
Health & Fitness

Kosmoderma continues to be the big player in the skincare industry with its new and innovative launch

by My UP Desk
July 21, 2023
Sakra World Hospital Launches Comprehensive Facial Palsy Care Centre
Health & Fitness

Sakra World Hospital Launches Comprehensive Facial Palsy Care Centre

by My UP Desk
July 18, 2023
Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

Sublethal exposure study of lead (Pb) on black clams to provide early warning information on marine pollution

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent News

The Circle: Founders Club launches Market Access focused Accelerator Program for 10 Korean startups in India

The Circle: Founders Club launches Market Access focused Accelerator Program for 10 Korean startups in India

September 29, 2023
Cherise Heartwarming Gesture: Free 2 lac Tea Distribution Daily for 10 Days at Lalbaughcha Raja Ganesh Mahotsav 2023

Cherise Heartwarming Gesture: Free 2 lac Tea Distribution Daily for 10 Days at Lalbaughcha Raja Ganesh Mahotsav 2023

September 28, 2023
Veeram Securities Limited Shines as a Leading Player in India’s Jewelry and Ornaments Industry

Veeram Securities Limited Shines as a Leading Player in India’s Jewelry and Ornaments Industry

September 27, 2023
Mr. Ashutosh Landge appointed as President IT and Communications Vertical, The BRICS Chamber of Commerce and Industry

Mr. Ashutosh Landge appointed as President IT and Communications Vertical, The BRICS Chamber of Commerce and Industry

September 27, 2023
M Plus Beats Unveils ‘Koi Apna Nahi Hota’ – The Heartbreak Anthem of the Season

M Plus Beats Unveils ‘Koi Apna Nahi Hota’ – The Heartbreak Anthem of the Season

September 23, 2023

Browse by Category

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Health & Fitness
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • Uncategorized
  • Uttar Pradesh
  • World

Categories

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Health & Fitness
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • Uncategorized
  • Uttar Pradesh
  • World

Browse by Tag

Ahmedabad Artificial intelligence Bengaluru Blockchain technology Content Creator Cryptocurrency CSIR DBT DeFi aggregators DeFi and NFT navigation tool DeFi industry DeFi spaces Delhi Department of Biotechnology DeSpace platform DeSpace Protocol Digital Marketing Dr. Jitendra Matlani Dr. Sandeep Marwah DST Dubai Education entrepreneur environment Fairplay Gujarat Healthcare Hyderabad IIT Delhi Influencer Influencerquipo K Raheja Corp Homes MoES Mumbai Music Industry NFT Noida photography PM Pune Sandeep Marwah social media social media influencer Surat TTK Prestige

Recent Posts

  • The Circle: Founders Club launches Market Access focused Accelerator Program for 10 Korean startups in India
  • Cherise Heartwarming Gesture: Free 2 lac Tea Distribution Daily for 10 Days at Lalbaughcha Raja Ganesh Mahotsav 2023
  • Veeram Securities Limited Shines as a Leading Player in India’s Jewelry and Ornaments Industry
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

© 2022 My Uttar Pradesh

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 My Uttar Pradesh

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?